-
CRMD Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
CorMedix (CRMD)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 35.39 mm | 35.39 mm | 35.39 mm | 35.39 mm | 35.39 mm | 35.39 mm |
Cash burn (monthly) | (no burn) | 1.51 mm | 1.10 mm | 4.25 mm | 4.55 mm | 4.65 mm |
Cash used (since last report) | n/a | 6.07 mm | 4.41 mm | 17.08 mm | 18.30 mm | 18.68 mm |
Cash remaining | n/a | 29.32 mm | 30.98 mm | 18.31 mm | 17.09 mm | 16.71 mm |
Runway (months of cash) | n/a | 19.4 | 28.3 | 4.3 | 3.8 | 3.6 |
13F holders | Current |
---|---|
Total holders | 102 |
Opened positions | 19 |
Closed positions | 15 |
Increased positions | 38 |
Reduced positions | 23 |
13F shares | Current |
---|---|
Total value | 148.89 bn |
Total shares | 19.11 mm |
Total puts | 441.30 k |
Total calls | 134.10 k |
Total put/call ratio | 3.3 |
Largest owners | Shares | Value |
---|---|---|
BlackRock | 3.66 mm | $29.54 bn |
Vanguard | 3.07 mm | $24.79 bn |
Elliott Investment Management | 1.55 mm | $12.53 bn |
Rosalind Advisors | 1.48 mm | $11.92 bn |
Geode Capital Management | 1.28 mm | $10.38 bn |
STT State Street | 1.23 mm | $9.90 bn |
Voya Investment Management | 711.95 k | $5.75 bn |
NTRS Northern Trust | 447.32 k | $3.61 bn |
Kennedy Capital Management | 379.94 k | $3.07 bn |
MS Morgan Stanley | 342.39 k | $2.77 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
17 Jan 25 | Gregory Scott Duncan | Common Stock | Grant | Acquire A | No | No | 0 | 25,000 | 0.00 | 25,000 |
17 Jan 25 | Steven W Lefkowitz | Common Stock | Grant | Acquire A | No | No | 0 | 25,000 | 0.00 | 100,498 |
17 Jan 25 | Kaplan Myron | Common Stock | Grant | Acquire A | No | No | 0 | 25,000 | 0.00 | 176,034 |
17 Jan 25 | Dillione Janet | Common Stock | Grant | Acquire A | No | No | 0 | 25,000 | 0.00 | 78,473 |
17 Jan 25 | Robert A Stewart | Common Stock | Grant | Acquire A | No | No | 0 | 25,000 | 0.00 | 36,000 |